Portfolio Review Committee

Hatteras Discovery collaborates with a Committee of scientists, Biopharma executives and serial entrepreneurs charged with providing advisory opinions of companies in which investments have been placed. The Committee provides expert input toward business, scientific, and development aspects of the companies. The Committee also reviews the annual goals and areas of interests from a therapeutic perspective.

Moncef Slaoui, PhD — Chairman, R&D of GSK, PRC Chair

Herb Boyer, PhD — Co-Founder of Genentech, Professor Emeritus of Biochemistry and Biophysics

Joe Cook, Jr. — Former CEO and Chairman of Amylin

Richard Flavell, PhD — Howard Hughes Institute, Chair of Immunology, co-founder of several successful biotech companies, Chair of Immunology at Yale School of Medicine

Colin Goddard, PhD — Founder and Former CEO of OSI, CEO of Coferon

Special Advisor:
Cam Patterson, MD — Chief of UNC Cardiology, Physician-in-Chief, UNC Center for Heart and Vascular Care, Associate Dean for Health Care Entrepreneurship